Innovation insights for life sciences

As Elsevier’s report on AI attitudes sparks conversation in the research and health communities, co-author Adrian Mulligan comments on its significance for corporate R&D

Discover how research-intensive companies are navigating the perils and pitfalls of AI. Hear from experts about AI changing innovation and R&D processes to drive better business outcomes.

Watch the webinars:

Johnson Matthey on foundations for effective AI 新しいタブ／ウィンドウで開く

The perils and pitfalls of generative AI for R&D 新しいタブ／ウィンドウで開く

Drug repurposing can significantly reduce timelines and cost compared with de novo drug development. Explore drug repurposing topics, including:

• 3 approaches to drug repurposing

• Drug repurposing methods

• Drug repurposing challenges

Dive into innovative methodologies, cutting-edge research and ethical considerations aimed at fostering a future without animal testing in a recorded webinar series featuring the following experts:

• Successful alternatives to animal testing 新しいタブ／ウィンドウで開く

  • Gail Van Norman, Professor Emeritus, University of Washington

  • Thomas Hartung, Johns Hopkins Bloomberg School of Public Health

• Successful AI alternatives to animal testing 新しいタブ／ウィンドウで開く

  • Dr. Weida Tong, FDA’s National Center for Toxicological Research

• Successful alternatives to animal testing: using virtual control groups 新しいタブ／ウィンドウで開く

  • Matthew Clark, Charles River Laboratories

Medical device regulation (MDR) compliance is a challenge for medical device companies. Review key topics in MDR and access a popular webinar series to avoid errors in securing device approvals:

• MDR throughout the product lifecycle

• Trends and challenges in MDR

• Why do regulatory submissions and applications get rejected?

• MDR webinars on navigating compliance challenges and achieving certification